心血管病防治知识（下半月）
心血管病防治知識（下半月）
심혈관병방치지식（하반월）
XINXUEGUANBING FANGZHI ZHISHI
2014年
9期
90-92
,共3页
心力衰竭%老年重症%急诊内科%临床疗效
心力衰竭%老年重癥%急診內科%臨床療效
심력쇠갈%노년중증%급진내과%림상료효
Heart failure%Elderly patient with severe heart failure%Emergency medicine%Clinical efficacy
目的：研究老年重症心力衰竭急诊内科的临床治疗效果。方法选取我院2013年1月至2014年1月间收治的重症心力衰竭急诊内科病患80例，将病患随机地划分成对照组和观察组，对照组采用常规疗法，观察组在常规疗法的基础上，选用美托洛尔合并厄贝沙坦氢氯噻嗪的方式完成治疗，观察并对比两组的临床疗效，对临床结果开展回顾性分析。结果对照组的疗效，3例为优，占7.5％，26例为良，占65.0％，11例为差，占27.5％，本组治疗的总有效率为72.5％；观察组的疗效，8例为优，占20.0％，31例为良，占77.5％，1例为差，占2.5％，本组治疗的总有效率为97.5％。两组病患在疗效优良率方面有显著性差异，P﹤0.05表明具备统计学意义。结论运用美托洛尔合并厄贝沙坦氢氯噻嗪治疗老年重症心力衰竭的临床效果显著，是一类可靠、理想的疗法，值得临床推广和应用。
目的：研究老年重癥心力衰竭急診內科的臨床治療效果。方法選取我院2013年1月至2014年1月間收治的重癥心力衰竭急診內科病患80例，將病患隨機地劃分成對照組和觀察組，對照組採用常規療法，觀察組在常規療法的基礎上，選用美託洛爾閤併阨貝沙坦氫氯噻嗪的方式完成治療，觀察併對比兩組的臨床療效，對臨床結果開展迴顧性分析。結果對照組的療效，3例為優，佔7.5％，26例為良，佔65.0％，11例為差，佔27.5％，本組治療的總有效率為72.5％；觀察組的療效，8例為優，佔20.0％，31例為良，佔77.5％，1例為差，佔2.5％，本組治療的總有效率為97.5％。兩組病患在療效優良率方麵有顯著性差異，P﹤0.05錶明具備統計學意義。結論運用美託洛爾閤併阨貝沙坦氫氯噻嗪治療老年重癥心力衰竭的臨床效果顯著，是一類可靠、理想的療法，值得臨床推廣和應用。
목적：연구노년중증심력쇠갈급진내과적림상치료효과。방법선취아원2013년1월지2014년1월간수치적중증심력쇠갈급진내과병환80례，장병환수궤지화분성대조조화관찰조，대조조채용상규요법，관찰조재상규요법적기출상，선용미탁락이합병액패사탄경록새진적방식완성치료，관찰병대비량조적림상료효，대림상결과개전회고성분석。결과대조조적료효，3례위우，점7.5％，26례위량，점65.0％，11례위차，점27.5％，본조치료적총유효솔위72.5％；관찰조적료효，8례위우，점20.0％，31례위량，점77.5％，1례위차，점2.5％，본조치료적총유효솔위97.5％。량조병환재료효우량솔방면유현저성차이，P﹤0.05표명구비통계학의의。결론운용미탁락이합병액패사탄경록새진치료노년중증심력쇠갈적림상효과현저，시일류가고、이상적요법，치득림상추엄화응용。
Objective To investigate the clinical efficacy of emergency treatment in elderly patients with severe heart failure. Methods Eighty patients with severe heart failure admitted to the emergency medicine division of our hospital from January 2013 to January 2014 were randomly divided into control group and observation group. The control group received conventional treatment, while the observation group received metoprolol combined with irbesartan and hydrochlorothiazide in addition to the conventional treatment. The clinical outcomes of the two groups were compared, and the clinical results were retrospectively analyzed. Results In the control group, 3 cases (7.5%) showed excellent response, 26 cases (65.0%) showed good response, and 11 cases (27.5%) showed poor response, with an overall response rate of 72.5%. In the observation group, 8 cases (20.0%) showed excellent response, 31 cases (77.5%) showed good response, and 1 case (2.5%) showed poor response, with an overall response rate of 97.5%. The excellent/good response rate showed a significant difference between the two groups (P﹤0.05). Conclusion Metoprolol combined with irbesartan and hydrochlorothiazide has significant clinical efficacy in elderly patients with severe heart failure. This therapy is reliable and ideal and holds promise for clinical application.
